PI
BPMC

PineBridge Investments’s Blueprint Medicines BPMC Stock Holding History

PineBridge Investments’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-734
Closed -$46.4K – 726
2023
Q2 		$46.4K Buy
+734
New +$39.9K ﹤0.01% 656

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PineBridge Investments's BPMC Position: Q3 2023 in Review

PineBridge Investments sold out of Blueprint Medicines (BPMC) in Q3 2023, closing a stake of 734 shares — an estimated $46.4K sold.

PineBridge Investments first reported a position in BPMC in Q2 2023 and held it in 1 quarter. The position peaked at $46.4K in Q2 2023. 220 funds tracked by Wall St. Rank hold BPMC as of Q3 2023.

  • PineBridge Investments reported no remaining Blueprint Medicines position as of Q3 2023 after selling out during the quarter.
  • PineBridge Investments sold 734 Blueprint Medicines shares in Q3 2023, an estimated $46.4K.
  • PineBridge Investments first reported a position in Blueprint Medicines in Q2 2023 and held it in 1 quarter.
  • PineBridge Investments's Blueprint Medicines position peaked at $46.4K in Q2 2023.
  • 220 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2023.

Based on PineBridge Investments's 13F filing for Q3 2023, filed 14 Nov 2023.